rs1021631442
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000179.3(MSH6):c.3722G>A(p.Cys1241Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Lynch syndrome Pathogenic:1
The MSH6 p.C1241Y variant has has been reported once in a woman with ovarian cancer (Pal 2012). The variant occurs at a position that is evolutionarily conserved. Testing performed on tumor tissue of a patient with constitutional MSH6 p.C1241Y variant supports that this variant is likely pathogenic. Specifically, in the patient's tumor the constitutional MSH6 variant was seen with a single somatic mutation at heterozygous freqency in MSH6 in the tumor, without evidence of loss of heterozygosity at MSH6 . -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.C1241Y variant (also known as c.3722G>A), located in coding exon 8 of the MSH6 gene, results from a G to A substitution at nucleotide position 3722. The cysteine at codon 1241 is replaced by tyrosine, an amino acid with highly dissimilar properties. In one study, this alteration was detected in 1/1893 individuals with epithelial ovarian cancer and was predicted to be pathogenic based on in silico prediction models (Pal T et al. Br. J. Cancer 2012 Nov; 107(10):1783-90). This alteration has been observed in at least one individual with a personal and/or family history that is consistent with MSH6-related disease (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MSH6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 428361). This missense change has been observed in individual(s) with clinical features of Lynch syndrome (PMID: 23047549, 30877237). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 1241 of the MSH6 protein (p.Cys1241Tyr). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at